ABH Healthcare IPO Opens August 24, Grey Market Premium Signals Up To 29% Listing Gain

ABH Healthcare Limited, a multi-specialty healthcare services provider operating under the Anil Baghi Hospital brand, is set to launch its ₹34.98 crore initial public offering (IPO) on August 24, 2026. The shares are expected to list on the NSE SME platform on September 1. The IPO has garnered significant interest, with the grey market premium (GMP) currently ranging from ₹27 to ₹30 per share, indicating an anticipated premium of 26.5%-29.4%.

However, the GMP is unofficial and subject to rapid change before the actual listing. The company has fixed its IPO price band at ₹96-₹102 per share, with a face value of ₹10 per share. The lot size is 1,200 shares, and retail investors are required to apply for a minimum of two lots, or 2,400 shares, amounting to an investment of ₹2.45 lakh at the upper price band.

The IPO consists of 34,29,600 equity shares, with 1,72,800 reserved for market makers and the remaining 32,56,800 available for public subscription. The proceeds will be utilized for debt repayment, working capital needs, and unidentified acquisitions. ABH Healthcare has reported improved financial performance, with consolidated revenue rising from ₹41.38 crore in FY24 to ₹52.51 crore in FY26.

EBITDA has more than doubled from ₹6.89 crore to ₹14.72 crore, and profit after tax increased from ₹1.66 crore to ₹5.64 crore. The company's EBITDA margin improved from 16.66% to 28.03%, and the return on equity stood at 39.07% in FY26. ABH Healthcare currently runs a 150-bed hospital offering services across 25 medical specialities.